Morning Alert : Actavis (NYSE:ACT), Borderfree (NASDAQ:BRDR), (NASDAQ:SOHU), Rowan Companies (NYSE:RDC), Platform Specialty Products (NYSE:PAH)

Actavis plc’s (NYSE:ACT) new drug application (NDA) for its antibiotic candidate, ceftazidime-avibactam, has been accepted for review by the FDA. Actavis is looking to get ceftazidime-avibactam approved for the treatment of patients with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), including those caused by multi-drug resistant gram-negative bacterial pathogens. Actavis plc (NYSE:ACT) belongs to Healthcare sector. Its net profit margin is 0.60% and weekly performance is 2.64%. On last trading day company shares ended up $232.97. Actavis plc (NYSE:ACT) distance from 50-day simple moving average (SMA50) is 6.48%.

On 2 Sep 2014 Borderfree (NASDAQ:BRDR), a market leader in international cross-border ecommerce solutions, today announced that Michael DeSimone, Chief Executive Officer, and Ed Neumann, Chief Financial Officer, will present at the Credit Suisse 5th Annual Small & Mid Cap Conference, to be held at The Waldorf Astoria in New York on Tuesday, September 16 at 1:50 PM ET. Borderfree, Inc. (NASDAQ:BRDR) shares moved down -0.78% in last trading session and ended the day at $14.05. BRDR Gross Margin is 33.80% and its return on assets is -2.70%. Borderfree, Inc. (NASDAQ:BRDR) quarterly performance is -11.64%.

On July 28, 2014, Inc. (NASDAQ:SOHU) announced its unaudited financial results for the second quarter ended June 30, 2014. A copy of the press release issued by the registrant regarding the foregoing is filed herewith as Exhibit 99.1 and is incorporated herein by reference. On 08 September, Inc. (NASDAQ:SOHU) shares moved down -0.83% and was closed at $56.02. SOHU EPS growth in last 5 year was -16.00%. Inc. (NASDAQ:SOHU) year to date (YTD) performance is -23.19%.

On 2 Sep 2014 Rowan Companies plc’s (NYSE:RDC) share price rose by 1.5% on the news of it receiving the delivery of its second ultra deepwater drillship, Rowan Resolute. Rowan Companies plc (NYSE:RDC) ended the last trading day at $28.67. Company weekly volatility is calculated as 1.83%and price to cash ratio as 2.86. Rowan Companies plc (NYSE:RDC) showed a weekly performance of -5.44%.

On 7 Aug 2014 Platform Specialty Products Corporation (NYSE:PAH), a global specialty chemicals company, announced today that it has entered into an amendment to its credit agreement. Platform Specialty Products Corporation (NYSE:PAH) shares moved down -1.58% in last trading session and ended the day on $26.77. Platform Specialty Products Corporation (NYSE:PAH) quarterly performance is -2.44%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone